Диссертация (1140011), страница 17
Текст из файла (страница 17)
– P. 247–254.123.Mason, H. Polycystic ovary syndrome (PCOS) trilogy: a translational andclinical review / H. Mason [et al.] // Clinical Endocrinology. – 2008. – 69(6). – P. 831–844.113124.Massaki, A. B. Repigmentation of hypopigmented scars using an erbiumdoped 1,550-nm fractionated laser and topical bimatoprost / A. B. Massaki,S. G.
Fabi, R. Fitzpatrick // Dermatol Surg. – 2012. – 38(7 Pt1). – P. 995–1001.125.Matilainen, V. Early androgenetic alopecia as a marker of insulin resistance/ V. Matilainen, P. Koskela, S. Keinänen-Kiukaanniemi // Lancet. – 2000Sep 30. – 356 (9236). – P. 1165–6.126.Matilainen, V. Hair loss, insulin resistance, and heredity in middleagedwomen. A population-based study / V. Matilainen [et al.] // J CardiovascRisk.
– 2003. – 10. – P. 227–31.127.Messenger, A. G. Follicular miniaturization in female pattern hair loss:clinicopathological correlations / A. G. Messenger, R. Sinclair // Br JDermatol. – 2006 Nov. – 155 (5). – P. 926–30.128.Michelet, J. F. Activation of cytoprotective prostaglandin synthase-1 byminoxidil as a possible explanation for its hair growth-stimulating effect /J. F. Michelet [et al.] // J Invest Dermatol. – 1997 Feb. – 108 (2).
– P. 205–9.129.Morganti, P. Effect of gelatin-cystine and serenoarepens extract on freeradicals level and hair growth / P. Morganti [et al.] // Journal of AppliedCosmetology. – 1998. – 16 (3). – P. 59–64.130.Nabaie, L. Androgenic alopecia and insulin resistance: Are they reallyrelated? / L. Nabaie [et al.] // Clin Exp Dermatol. – 2009. – 34. – P. 694–7.131.Norwood, O.T. Incidence of female androgenetic alopecia (female patternalopecia) / O. T.
Norwood // Dermatol Surg. – 2001. – 27. – P. 53–54.132.Nyholt, D. R. Genetic basis of male pattern baldness / D. R. Nyholt [et al.]// Journal of Investigative Dermatology. – 2003. – 121 (6). – P. 1561–1564.133.Olsen, E. A. Current and novel methods for assessing efficacy of hairgrowth promoters in pattern hair loss / E. A. Olsen // Journal of theAmerican Academy of Dermatology. – 2003.
– 48 (2). – P. 253–262.114134.Olsen, E. A. Evaluation and treatment of male and female pattern hair loss /E. A. Olsen [et al.] // Journal of the American Academy of Dermatology. –2005. – 52 (2). – P. 301–311.135.Olsen, E. A. Female pattern hair loss / E. A. Olsen // Journal of theAmerican Academy of Dermatology. – 2001. – 45. – P. 570–580.136.Olsen, E. A. Hair Growth and Disorders / E. A. Olsen, U. Blume-Peytavi.
–Berlin, Germany: Springer, 2006. – Vol. 26.137.Olsen, E. A. The middle part an important physical due to the diagnosis ofandrogenetic alopecia in women / E. A. Olsen // Journal of the AmericanAcademy of Dermatology. – 1999. – 48. – P. 253–262.138.Olsen, E. A. Topical minoxidil in the treatment of androgenetic alopecia inwomen / E. A. Olsen // Cutis. – 1991 Sep. – 48 (3). – P.
243–8.139.Orentreich, N. Biology of scalp hairgrowth / N. Orentreich, N. P. Durr //Clin. Plast. Surg. – 1982. – Vol.9. – P. 197–205.140.Paik, J. H. The prevalence and types of androgenetic alopecia in Koreanmen and women / J. H. Paik [et al.] // British Journal of Dermatology. –2001. – 145 (1). – P. 95–99.141.Paradisi, R. Prospective cohort study on the effects and tolerability offlutamide in patients with female pattern hair loss / R.
Paradisi [et al.] //Ann Pharmacother. – 2011. – 45 (4). – P. 469–75.142.Peereboom-Wynia, J. D. The effect of cyproterone acetate on hair roots andhair shaft diameter in androgenetic alopecia in females / J. D. PeereboomWynia [et al.] // Acta Derm Venereol. – 1989. – 69 (5). – P. 395–8.143.Prager, N. A randomized, double-blind, placebo-controlled trial todetermine the effectiveness of botanically derived inhibitors of 5-alphareductase in the treatment of androgenetic alopecia / N. Prager [et al.] // JAltern Complement Med. – 2002. – 8 (2).
– P. 143–152.144.Price, V.H. Lack of efficacy of finasteride in postmenopausal women withandrogenetic alopecia / V. H. Price [et al.] // J Am Acad Dermatol. – 2000Nov. – 43 (5 Pt 1). – P. 768–76.115145.Randall V.F. The role of 5a-reductase in health and disease // BaillieresClinical Endocrinology and Metabolism.
Vol. 8 Hormones, Enzymes andReceptors/ Eds M. Sheppard, P. Steward. – 1994. – P.405–431.146.Randall, V.A. The biology of androgenetic alopecia / Hair and itsDisorders. Biology, Pathology and Management // Eds F.M. Camacho,V.A. Randall, V.H. Price. – London; Martin Dunitz 2000. – P.123–136.147.Rathnayake, D. Innovativeuse of spironolactone as an antiandrogen in thetreatment of female pattern hair loss / D. Rathnayake, R. Sinclair //Dermatol Clin.
– 2010 Jul. – 28 (3). – P. 611–8.148.Reaven, G. M. Pathophysiology of insulin resistance in human disease / G.M. Reaven // Physiol. – 1995. – 75. – P. 473–86.149.Riedel-Baima, B. Female pattern hair loss may be triggered by lowoestrogen to androgen ratio / B. Riedel-Baima, A. Riedel // Endocr Regul.– 2008. – 42(1). – P. 13–6.150.Riedel-Baima, B. Use of the TrichoScan to Assess Female Pattern HairLoss / B. Riedel-Baima, A. Riedel // Dermatologic Surgery.
– Apr 2009. –Vol. – 35 Issue 4. – Р. 651–655.151.Rietschel, R. L. Safety and efficacy of topical minoxidil in the managementof androgenetic alopecia / R. L. Rietschel, S. H. Duncan // J Am AcadDermatol. – 16 (3 Pt 2). – P. 677–685.152.Rinaldi, F. The role of plateler rich plasma to control anagen phase:evaluation in vitro and in vivo in hair transplant and hair treatment / F.Rinaldi, E. Sorbenellini, T. Coscera // Int.
J. Trichol. – 2011 – Vol. 3, N 1.– P. S14.153.Roberts, J. L. Androgenetic alopecia: treatment results with topicalminoxidil / J. L. Roberts // J Am Acad Dermatol. – 1987. – 16 (3 Pt 2). – P.705–710.154.Ross, E. K. Videodermoscopy in the evaluation of hair and scalp disorders /E. K. Ross, C. Vincenzi, A. Tosti // J Am Acad Dermatol. – 2006. – 55(5).– P.
799–806.116155.Rushton, D. H. Quantitative assessment of spironolactone treatment inwomen with diffuse androgen-dependent alopecia / D. H. Rushton [et al.] //J Soc Cosmet Chem. – 1991. – 42. – P. 317–325.156.Rushton, D. H. The importance of adequate serum ferritin levels duringoral cyproterone acetate and ethinyloestradiol treatment of diffuseandrogen-dependent alopecia in women / D.
H. Rushton, I. D. Ramsay //Clinical Endocrinology. – 1992. – 36 (4). – P. 421–427.157.Rushton, D.H. Biochemical and trichological characterization of diffusealopecia in women / D. H. Rushton [et al.] // Br J Dermatol. – 1990. – 123.– P. 187–97.158.Saitoh, M. Human hair cycle / M. Saitoh [et al.] // J Invest Dermatol. –1970. – 54.
– P. 65–81.159.Sasmaz, S. The risk of coronary heart disease in men with androgeneticalopecia / S. Sasmaz [et al.] // J Eur Acad Dermatol Venereol. – 1999. – 12.– P. 123–5.160.Satino, J. L. Hair regrowth and increased hair tensile strength using theHairMax LaserComb for Low-Level Laser Therapy / J. L. Satino, M.Markou // Int J Cos Surg Aest Dermatol. – 2003.
– 5. – P. 113–117.161.Savin, R.C. Evaluating androgenetic alopecia in male and female patients /R. C. Savin, M. I. Kalamazoo // The Upjohn Company. – 1994.162.Sawaya, M. E. Different levels of 5alpha-reductase type I and II,aromatase, and androgen receptor in hair follicles of women and men withandrogenetic alopecia / M.
E. Sawaya, V. H. Price // J Invest Dermatol. –1997. – 109. – P. 296–300.163.Schmidt, J. B. Hormone studies in females with androgenic hair loss / J. B.Schmidt [et al.] // Gynecol Obstet Invest. – 1991. – 31. – P. 235–9.164.Schweikert, H. Regulation ofhuman hair growth by steroid hormones.Testosterone metabolism in isolated hair / H. Schweikert, J. D. Wilson // J.Clin. Endocrinol. Metab. – 1974. – Vol. 40. – P. 413–417.117165.Shapiro, J. Clinical practice. Hair loss in women / J. Shapiro // N Eng JMed. – 2007. – 357 (16).
– P. 1620–30.166.Shapiro, J. Practical management of hair loss / J. Shapiro, M. Wiseman, H.Lui // Canadian Family Physician. – 2000. – 46. – P. 1469–1477.167.Shaw, J. C. Antiandrogen therapy in dermatology / J. C. Shaw // Int JDermatol. – 1996. – 35(11). – P. 770–8.168.Shaw, J. C. White LE. Long-term safety of spironolactone in acne: resultsof an 8-year follow up study / J. C.
Shaw // J Cutan Med Surg. – 2002. –6(6). – P. 541–5.169.Sinclair, R. The reliability of horizontally sectioned scalp biopsies in thediagnosis of chronic diffuse telogen hair loss in women / R. Sinclair [et al.]// Journal of the American Academy of Dermatology. – 2004. – 51 (2). – P.189–199.170.Sinclair, R. Treatment of female pattern hair loss with oral antiandrogens /R. Sinclair, M. Wewerinke, D. Jolley // Br J Dermatol. – 2005. – 152 (3). –P. 466–73.171.Su, L. H. Association of androgenetic alopecia with smoking and itsprevalence among Asian men: a community-based survey / L. H.
Su, T. H.Chen // Archives of Dermatology. – 2007. – 143 (11). – P. 1401–1406.172.Su, L. H. Factors associated with female pattern hair loss and its prevalencein Taiwanese women: a community-based survey / L. H. Su, L. S. Chen, H.H. Chen // J Am Acad Dermatol. – 2013. – 69.
– P. 556–77.173.Tobin, D. J. Plasticity and cytokinetic dynamics of the hair folliclemesenchyme: Implications for hair growth control / D. J. Tobin [et al.] // JInvest Dermatol. – 2003. – 120. – P. 895–904.174.Tosti, A. Androgenetic alopecia / A. Tosti, B.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
